| Cash and cash equivalents |
395.14M |
| Accounts receivable |
3.99M |
| Other current assets |
22M |
| Total Current Assets |
434.74M |
| Property held for sale |
| Property and Equipment, net of accumulated depreciation and amortization of $15,338 and $14,963 |
35.62M |
| Patent Costs, net of accumulated amortization of $1,845 and $1,742 |
8.11M |
| Other assets |
8.05M |
| Total Assets |
487.31M |
| Accounts payable |
20.68M |
| Accrued employee compensation |
| Long-term debt, current portion |
| Warrant valuation |
| Deferred revenue |
3.3M |
| Other liabilities |
1.3M |
| Total Current Liabilities |
64.93M |
| Commitments and Contingencies |
0 |
| Long-term debt, non-current portion |
| Other long-term liabilities |
| Preferred stock, $.0001 par value, 20,000,000 shares authorized; none issued and outstanding |
0 |
| Common stock, $.0001 par value, 300,000,000 and 200,000,000 shares authorized; 135,685,068 and 112,352,452 issued and outstanding |
5K |
| Additional paid-in capital |
| Deficit accumulated during the development stage |
| Total Shareholders' Equity (Deficit) |
408.62M |
| Total Liabilities and Shareholders' Equity (Deficit) |
487.31M |
